PNC-28

PNC-28 is a synthetic peptide derived from a mitochondrial targeting sequence of p53, designed to selectively induce apoptosis in cancerous cells. This peptide functions by disrupting mitochondrial membranes in malignant cells while sparing healthy tissues, making it a promising research tool for studies focused on cancer biology and targeted peptide therapeutics.

PNC-28 plays an important role in modulating pathways of apoptosis and cellular stress response, with demonstrated activity against various tumor cell lines. It has shown potential in reducing tumor growth, enhancing cellular clearance mechanisms, and restoring balance to tissue environments compromised by malignant transformation.

In addition to its antitumor effects, PNC-28 may contribute to improved immune recognition of abnormal cells and support systemic resilience against cancer progression. PNC-28 offers a valuable compound for exploring therapeutic strategies related to oncology, apoptosis regulation, and cancer peptide research.

PNC-28 is provided in reconstituted vials or pre-pulled syringes for daily use, administered once per day subcutaneously in the abdomen, thigh, or upper arm. Dosage duration may vary based on individual needs and provider guidance. Store syringes in the refrigerator and follow all included instructions carefully. PNC-28 common doses include: 3 mg per injection. Dosages are increased based on tolerance and treatment goals. 

*All peptide sales are non‑refundable and non‑returnable. However, your satisfaction is important to us — if there is any problem with your order, please contact us right away and we will work with you to make it right.